Bluetrum(SH:688332) Zheng Quan Zhi Xing·2025-05-23 11:05Core Viewpoint - The company has adjusted the stock grant price for its 2023 restricted stock incentive plan from 28.61 CNY per share to 27.61 CNY per share due to the distribution of cash dividends [1][5]. Group 1: Decision Process and Disclosure - The board of directors and the supervisory board approved the adjustment of the stock grant price during their meetings, ensuring compliance with relevant regulations and procedures [1][5]. - The independent directors provided opinions on the scientific and reasonable nature of the incentive plan and its assessment indicators [1][2]. - The company disclosed the incentive plan and related information on the Shanghai Stock Exchange, including the self-inspection report regarding insider trading [2][3]. Group 2: Adjustment Methodology - The adjustment of the stock grant price is based on the company's capital reserve conversion, cash dividends, and other corporate actions, following specific formulas outlined in the incentive plan [4][5]. - The adjusted stock grant price was calculated by deducting the cash dividend of 1.00 CNY per share from the original price [4][5]. Group 3: Impact of Adjustment - The adjustment of the stock grant price is in accordance with the relevant laws and regulations and will not have a substantial impact on the company's financial status or operational results [5][6]. - The supervisory board agreed that the adjustment process was legally valid and did not harm the interests of the company or its shareholders [5][6]. Group 4: Legal Opinions - The legal opinion from Guangdong Xinda Law Firm confirmed that the necessary authorizations and approvals for the stock grant and price adjustment have been obtained, complying with applicable laws and regulations [6].